Americans battling Ebola fueled by faith -- and, in one case, Starbucks

    Just Watched

    Ebola doctor: Growing stronger every day

Ebola doctor: Growing stronger every day 02:26

Story highlights

  • Nancy Writebol and Dr. Kent Brantly contracted Ebola while helping others in Liberia
  • Both were flown home to the U.S. and are being treated at Emory University Hospital
  • Nancy Writebol's husband says she's not yet in the clear but "in very good hands"
  • Kent Brantly says his "focus ... remains the same -- to follow God"

Like the other American who volunteered to help others in Africa and ended up with Ebola, Nancy Writebol is driven first and foremost by her fervent faith.

Still, that doesn't mean she doesn't need -- or deserve -- a pick-me-up.

So, after arriving at Atlanta's Emory University Hospital from Liberia, Nancy Writebol asked for -- and received -- coffee from Starbucks. That was a definite plus about being back in her home country, though her husband acknowledges she has a long way to go to beat the deadly disease.

"I don't believe we can say she is in the clear, (but) I would say she is in very good hands," her husband, David Writebol, said Friday. "... I am praying like never before."

'Unassuming' woman of faith thrust into spotlight

    Just Watched

    Western Africa continues fight with Ebola

Western Africa continues fight with Ebola 01:40
PLAY VIDEO

On the same day he spoke about his wife's illness, the other infected American, who is being treated at the same Atlanta hospital, spoke publicly for the first time.

    Just Watched

    Go inside plane that held Ebola patients

Go inside plane that held Ebola patients 02:09
PLAY VIDEO

Dr. Kent Brantly said in a statement that he is receiving "the very best care possible" and "growing stronger every day."

    Brantly and the Writebols talked about what led them to Liberia, where they thrust themselves into the midst of poverty and disease with a mission focusing on those in need. They also spoke about their struggles now to overcome Ebola.

    Brantly, 33, went to Liberia with his wife and two children last year to serve a two-year fellowship through a Samaritan's Purse post-residency program to practice general medicine.

    Infected U.S. doctor long drawn to mission work

    But everything changed when Ebola started to sweep through West Africa. Brantly got a new role as medical director for the Samaritan's Purse Ebola Consolidated Case Management Center in Monrovia.

    "I held the hands of countless individuals as this terrible disease took their lives away from them," he said Friday. "I witnessed the horror firsthand and I can still remember every face and name."

    It was in Monrovia where Brantly said he "immediately isolated" himself after first feeling ill. Three days later, his Ebola diagnosis was confirmed, though it didn't trigger the emotional response one might expect.

    "When the result was positive, I remember a deep sense of peace that was beyond all understanding," he said. "God was reminding me of what he had taught me years ago, that he will give me everything I need to be faithful to him."

    Two weeks after that diagnosis, Brantly said, "My focus ... remains the same -- to follow God."

    WHO: Ebola an international health emergency

    That strong Christian faith also echoed throughout David Writebol's comments about his wife.

    Married for 40 years, the Writebols have traveled the globe focused on their faith and their desire to help others.

    They are an ocean apart now, though plans are in the works to bring David Writebol from Liberia to be with his wife in Atlanta. When they do reunite, David said, "I would give her a kiss. Hold her."

    After that, the couple wouldn't necessarily go back to the comforts of America and more coffee from Starbucks. Ebola might have derailed them, but it hasn't changed their purpose in life.

    "We aren't going to stop our ministry," David Writebol said. "We believe we can serve wherever God sends us."

    Ebola virus: 9 things to know about the killer disease

    Experimental drug likely saved Ebola patients

    9 questions about this new Ebola drug